Thursday, July 29, 2010
"The source for European pharmaceutical biotechnology news..."
Looming patent cliffs and shrivelling pipelines have pharma's big players looking for new business models that will allow them to increase their bottom lines.
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP Europe
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.06 Aug 2009
White Papers
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.